As of Sep 30, 2024, Zimmer Biomet Holdings, Inc.'s fair value using the Ben Graham formula is $603.1 per share. This is calculated using Ben Graham formula, where EPS is $5.3 and BVPS (Book Value Per Share) is $60.0. The current price of $109.6 suggests Zimmer Biomet Holdings, Inc. may be overvalued by this conservative metric.
Zimmer Biomet Holdings, Inc. earnings per share (EPS) for the twelve months ending Sep 30, 2024, was $5.3, a 62.6% growth year-over-year.
Zimmer Biomet Holdings, Inc.'s margin of safety is positive 450.5%, calculated as (Graham Number - Current Price) / Current Price. A negative margin of safety suggests the stock doesn't provide the level of safety Graham typically sought in his investments.